Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center
Clinical Oral Investigations · 2025
DOI: 10.1007/s00784-025-06519-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Oral Investigations, 2025. Verfasst von Raphael de Lima Chaparin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente, 211, Liberdade, São Paulo, 01509-900, SP, Brazil. Hauptthemen laut MEDLINE: Dental Implants, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: The aim of this study was to evaluate the clinicoradiological features and treatment approaches of MRONJ in cancer patients rehabilitated with osseointegrated implants. MATERIALS AND METHODS: Medical records of 147 patients who developed MRONJ over a 16-year period were evaluated. Demographic data, type of antiresorptive medication (AR) used, route of administration, frequency, and time of use were collected. Staging, clinical and imaging characteristics, and treatment for MRONJ were also collected. RESULTS: A total of 25 patients (17%) presented with implants in the region affected by MRONJ, of whom 23 (92%) underwent implant placement prior to the initiation of AR. The total number of affected implants was 42 and most had an external hexagon connection (n = 25, 59.5%). Among these patients, 28 MRONJ areas were identified, most of which were classified as stage 2 (n = 17, 60.7%) and located in the posterior mandible (n = 16, 57.1%). Pain (n = 17, 68%) and the presence of osteolytic areas (n = 21, 84%) were the most commonly observed clinical and imaging characteristics. Surgical treatment was the preferred approach in 84% (n = 21) of cases. CONCLUSIONS: MRONJ involving implants occurred mainly in patients rehabilitated before AR, with frequent involvement of the posterior mandible, pain, and osteolytic areas on radiological imaging. Surgical intervention showed a high rate of clinical success. CLINICAL RELEVANCE: Implants placed prior to AR may act as local risk factors for MRONJ in cancer patients, underscoring the need for careful evaluation of existing implants before starting treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente, 211, Liberdade, São Paulo, 01509-900, SP, Brazil.
- Department of Stomatology, São Paulo University, São Paulo, SP, Brazil.
- Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- Department of Stomatology, A.C. Camargo Cancer Center, Rua Prof. Antônio Prudente, 211, Liberdade, São Paulo, 01509-900, SP, Brazil. falves@accamargo.org.br.
- Department of Stomatology, São Paulo University, São Paulo, SP, Brazil. falves@accamargo.org.br.
Zitieren
APA
de Lima Chaparin, R., de Lima Medeiros, Y., Figueiredo, R., Jaguar, G. C., Lopes, R. N., Rocha, A. C., & Alves, F. A. (2025). Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center. Clinical Oral Investigations. https://doi.org/10.1007/s00784-025-06519-7
Vancouver
de Lima Chaparin R, de Lima Medeiros Y, Figueiredo R, Jaguar GC, Lopes RN, Rocha AC, et al. Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center. Clinical Oral Investigations. 2025. doi:10.1007/s00784-025-06519-7
BibTeX
@article{deLimaChaparin2025,
author = {de Lima Chaparin, Raphael and de Lima Medeiros, Yuri and Figueiredo, Rui and Jaguar, Graziella Chagas and Lopes, Rodrigo Nascimento and Rocha, André Caroli and Alves, Fabio Abreu},
title = {Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center},
journal = {Clinical Oral Investigations},
year = {2025},
doi = {10.1007/s00784-025-06519-7}
}
EUVIMED